SELECT Trial Data Reveals GLP-1 Medications Boost Longevity Beyond Weight Loss
Explore how SELECT trial data reveals GLP-1 medications’ potential in boosting longevity beyond just weight loss, with significant cardiovascular benefits.
Novo Nordisk
SELECT Trial Reveals GLP-1 Drugs Could Extend Life Beyond Weight Loss
Discover how SELECT Trial data signals that GLP-1 drugs may impact longevity beyond weight loss, unveiling a $50 billion market opportunity.